Daily non-political popular news in brief.
Other patients bear the real cost of Herceptin
11-23-2006 · EurekAlert!The real cost of Herceptin is born by other patients whose treatment has to be dropped to balance the books, say doctors in this week’s BMJ.New guidance from the National Institute for health and Clinical Excellence (NICE) recommends trastuzumab (Herceptin) in early breast cancer, but it provides no extra funding and does not suggest what cuts should be made to release this extra money. This leaves medical staff with difficult decisions to make.
Read more »
Keywords: patients, bear, real, cost, herceptin, patient
« Previous | Next »
Similar news on "Other patients bear the real cost of Herceptin":
- Gene patenting -- steep cost for health care and patients
05-07-2007 · EurekAlert!
The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
Similar news · Read more »
- A new focus for health care reform -- realigning competition around patient value
03-13-2007 · EurekAlert!
The health care policy debate is stuck in a place that undermines physicians and the nation's health. The real problem is not cost, but value, according to an article in the March 14 issue of JAMA, a theme issue on access to care.
Similar news · Read more »
- Rheumatoid arthritis sends many into early retirement
02-04-2008 · EurekAlert!
A joint study on "The Burden of Rheumatoid Arthritis and Patient Access to Treatments" by authors from the Stockholm School of Economics, the University of Lund and the Medical University of Vienna has shown that the highest cost in rheumatoid arthritis results from patients having to leave the workforce early due to the disease. The study has just been published online in a supplement to Springer's The European Journal of Health Economics.
Similar news · Read more »
- Due to cost, heart attack patients often avoid follow-up care and medication
03-13-2007 · EurekAlert!
A lack of funds to pay for medical treatment and prescriptions is common among heart attack patients and leads to a worse recovery, more angina, poorer quality of life and higher risk of re-hospitalization, according to a study by researchers at Yale School of Medicine. Published in the March 14 issue of Journal of the American Medical Association (JAMA), the study sought to determine if self-reported financial barriers to health care services or medication were associated with worse patient outcomes.
Similar news · Read more »
- CAM-oriented primary care providers result in cost savings, high patient satisfaction
06-07-2007 · EurekAlert!
Patients visiting chiropractors and other holistically-oriented physicians who serve as primary care physicians have lower utilization costs and higher patient satisfaction levels than patients treated by conventional medical doctors, according to a recent study.
Similar news · Read more »
- Patient adherence for successful tuberculosis treatment
03-27-2007 · EurekAlert!
Existing treatment against Tuberculosis is effective but long and many patients abandon it before the end or take their doses at excessively long intervals. In order to improve patients' adherence to treatment, IRD researchers are putting the emphasis on adaptation of control strategies to patients' real geographical, social, health and cultural situation. Trials conducted in Senegal showed the effectiveness of such an approach, which should limit the spread of the disease and the emergence of new resistant strains.
Similar news · Read more »
- Study calculates patient time costs associated with cancer care
01-02-2007 · EurekAlert!
In 2005, the overall cost of patients' time spent on cancer care was $2.3 billion in the first year after diagnosis, according to a new study in the Jan. 3 issue of the Journal of the National Cancer Institute. The time costs for the 11 cancers studied and for different phases of cancer care varied widely, they write.
Similar news · Read more »
- As dialysis becomes a target of cost control, doctor-patient relationship is key
06-13-2007 · EurekAlert!
As medical, economic, and policy trends converge to alter the way dialysis care is organized and financed, protecting the unique relationship between dialysis patients and the kidney specialists who direct their care is a top priority, according to a special feature in the July Journal of the American Society of Nephrology.
Similar news · Read more »
- Cost control measures limit patient and physician choice in psychotropic medications
03-01-2007 · EurekAlert!
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University.
Similar news · Read more »
- Mayo Clinic real-time 3-D ultrasound speeds patient recovery
07-13-2007 · EurekAlert!
Mayo Clinic physicians have adapted real-time 3-D ultrasound imaging devices -- including one designed to look at an infant's heart -- so that they can watch as they use a needle filled with anesthetic to numb individual nerves located inches under the skin. In this way, they can quickly block nerve function in selected areas of the body prior to surgery, an advance that may spare patients from use of general anesthesia, and sends them home faster and with less need for pain medication.
Similar news · Read more »
